Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 5/2013

01-10-2013 | Letter to the Editor

Comment on: acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus

Authors: Turgay Ulas, Mehmet Sinan Dal, Irfan Tursun, Mehmet Emin Demir, Hakan Buyukhatipoglu

Published in: Acta Diabetologica | Issue 5/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Chang CM, Hsieh CJ, Huang JC, Huang IC (2012) Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol [Epub ahead of print]
2.
Buyukhatipoglu H, Sezen Y, Yildiz A et al (2010) N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. Pol Arch Med Wewn 120:383–389PubMed
3.
Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef
4.
Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119PubMedCrossRef
Metadata
Title
Comment on: acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus
Authors
Turgay Ulas
Mehmet Sinan Dal
Irfan Tursun
Mehmet Emin Demir
Hakan Buyukhatipoglu
Publication date
01-10-2013
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 5/2013
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-012-0423-0

Other articles of this Issue 5/2013

Acta Diabetologica 5/2013 Go to the issue

Original Article

Prevalence of mitochondrial diabetes in southwestern Finland: a molecular epidemiological study

Original Article

Association between protein signals and type 2 diabetes incidence

Case Report

Severely fibrotic pancreases from young patients with chronic pancreatitis: evidence for a ductal origin of islet neogenesis

Original Article

High meat consumption is associated with type 1 diabetes mellitus in a Sardinian case–control study

Original Article

A replacement for islet equivalents with improved reliability and validity

Original Article

Measurement and validation of the nature of salivary adiponectin
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits